Did you know that there’s a condition called “hypoactive sexual desire disorder,” from which many women suffer? Well, there is, or at least a bunch of scientists have decided there is, and sadly, about 10 percent of premenopausal women grapple with it. Luckily, if unsurprisingly, there might be a pill in the works for just this issue.
PT-141, a nasal spray that is perhaps the world’s first legitimate aphrodisiac, may hit the market in under three years. The Observer wonders whether such a “sure thing” will trivialize the emotional aspect of relationships.